MicroRNA and signaling pathways in gastric cancer
Open Access
- 25 July 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 21 (8), 305-316
- https://doi.org/10.1038/cgt.2014.37
Abstract
MicroRNAs (miRNAs) function as either oncogenes or tumor suppressors by inhibiting the expression of target genes, some of which are either directly or indirectly involved with canonical signaling pathways. The relationship between miRNAs and signaling pathways in gastric cancer is extremely complicated. In this paper, we determined the pathogenic mechanism of gastric cancer related to miRNA expression based on recent high-quality studies and then clarified the regulation network of miRNA expression and the correlated functions of these miRNAs during the progression of gastric cancer. We try to illustrate the correlation between the expression of miRNAs and outcomes of patients with gastric cancer. Understanding this will allow us to take a big step forward in the treatment of gastric cancer.Keywords
This publication has 200 references indexed in Scilit:
- Plasma microRNAs serve as novel potential biomarkers for early detection of gastric cancerMedical Oncology, 2013
- miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancerCell Death & Disease, 2012
- Lipid-based Nanoparticle Delivery of Pre-miR-107 Inhibits the Tumorigenicity of Head and Neck Squamous Cell CarcinomaMolecular Therapy, 2012
- Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancerCancer Letters, 2011
- Systemic Delivery of Tumor Suppressor microRNA Mimics Using a Neutral Lipid Emulsion Inhibits Lung Tumors in MiceMolecular Therapy, 2011
- MiR‐9 downregulates CDX2 expression in gastric cancer cellsInternational Journal of Cancer, 2011
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Origins and Mechanisms of miRNAs and siRNAsCell, 2009
- miR‐15b and miR‐16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cellsInternational Journal of Cancer, 2008